Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
RUM Group Inc
RUM
$3.76B
| $1.37M | ﹤0.01% |
152,952
+139,026
| +998% | +$1.19M |
|
3077
argenx
ARGX
$52.8B
| $1.37M | ﹤0.01% |
2,486
-66
| -3% | -$38.3K |
|
|
NAGE
3078
Niagen Bioscience
NAGE
$241M
| $1.37M | ﹤0.01% |
95,056
+41,256
| +77% | +$407K |
|
3079
CALL
Freeport-McMoran
FCX
$94.2B
| $1.37M | ﹤0.01% |
31,500
-24,700
| -44% | -$938K |
|
|
STKL
3080
DELISTED
SunOpta
STKL
| $1.36M | ﹤0.01% |
234,957
+83,383
| +55% | +$438K |
|
|
HERE
3081
Here Group Ltd
HERE
$97.9M
| $1.36M | ﹤0.01% |
+143,672
| New | +$1M |
|
3082
PDF Solutions
PDFS
$2.13B
| $1.36M | ﹤0.01% |
63,405
+21,439
| +51% | +$406K |
|
3083
Miller Industries
MLR
$640M
| $1.35M | ﹤0.01% |
30,467
+7,245
| +31% | +$315K |
|
3084
CALL
Bristol-Myers Squibb
BMY
$130B
| $1.35M | ﹤0.01% |
+29,200
| New | +$1.43M |
|
|
HONE
3085
DELISTED
HarborOne Bancorp
HONE
| $1.35M | ﹤0.01% |
115,662
+19,956
| +21% | +$218K |
|
3086
Sana Biotechnology
SANA
$1.06B
| $1.35M | ﹤0.01% |
494,415
-7,028
| -1% | -$14.5K |
|
3087
Bank of Montreal
BMO
$130B
| $1.35M | ﹤0.01% |
12,158
+2,488
| +26% | +$251K |
|
|
UDMY
3088
DELISTED
Udemy
UDMY
| $1.34M | ﹤0.01% |
191,282
+75,046
| +65% | +$518K |
|
|
TRST
3089
Trustco Bank Corp NY
TRST
$979M
| $1.34M | ﹤0.01% |
40,191
+11,622
| +41% | +$358K |
|
3090
CALL
Trip.com Group
TCOM
$28.3B
| $1.34M | ﹤0.01% |
+22,900
| New | +$1.38M |
|
|
LENZ
3091
LENZ Therapeutics
LENZ
$152M
| $1.34M | ﹤0.01% |
45,810
+21,409
| +88% | +$582K |
|
3092
Hovnanian Enterprises
HOV
$786M
| $1.34M | ﹤0.01% |
12,839
+3,523
| +38% | +$345K |
|
|
ONT
3093
Onterris Inc
ONT
$615M
| $1.34M | ﹤0.01% |
61,267
+20,283
| +49% | +$364K |
|
3094
Gray Television
GTN
$532M
| $1.34M | ﹤0.01% |
296,017
+139,720
| +89% | +$541K |
|
3095
West Fraser Timber
WFG
$5.42B
| $1.34M | ﹤0.01% |
18,276
+16,513
| +937% | +$1.23M |
|
3096
FLEX LNG
FLNG
$1.66B
| $1.34M | ﹤0.01% |
60,918
+15,440
| +34% | +$362K |
|
3097
Matthews International
MATW
$722M
| $1.34M | ﹤0.01% |
55,980
+18,707
| +50% | +$394K |
|
|
MCW
3098
DELISTED
Mister Car Wash
MCW
| $1.34M | ﹤0.01% |
222,423
+69,022
| +45% | +$485K |
|
|
QXO.PRB
3099
QXO Inc 5.50% Series B Preferred Stock
QXO.PRB
$499M
| $1.33M | ﹤0.01% |
+21,523
| New | +$1.26M |
|
3100
Beyond Meat
BYND
$6.59B
| $1.33M | ﹤0.01% |
12,727
+1,108
| +10% | +$96.3K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.